Showing results (181-190 of 295) with videos related to
Sort By:
Pageof 30
Atherosclerosis|December 2, 1999
Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective studyK Y Forrest, D J Becker, L H Kuller, et al.Stroke|March 1, 1993
Predictors of carotid stenosis in older adults with and without isolated systolic hypertensionK Sutton-Tyrrell, H G Alcorn, S K Wolfson, et al.Diabetes Care|May 1, 1982
Potentiometric measurement of glucose concentration with an immobilized glucose oxidase/catalase electrodeL B Wingard, C C Liu, S K Wolfson, et al.Stroke|March 1, 1997
Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal womenH C Lassila, K S Tyrrell, K A Matthews, et al.AJNR. American Journal of Neuroradiology|March 1, 1985
Cerebral magnetic resonance image synthesisS A Bobman, S J Riederer, J N Lee, et al.AJNR. American Journal of Neuroradiology|September 1, 1994
Neurologic complications of cerebral angiographyJ E Heiserman, B L Dean, J A Hodak, et al.Antimicrobial Agents and Chemotherapy|August 1, 1995
OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosaF Danel, L M Hall, D Gur, et al.Antimicrobial Agents and Chemotherapy|April 1, 1997
OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strainF Danel, L M Hall, D Gur, et al.Medical Physics|March 1, 1979
Relative measurements of fast neutron contamination in 18-MV photon beams from two linear accelerators and a betatronD Gur, G Bukovitz, J C Rosen, et al.Antimicrobial Agents and Chemotherapy|December 3, 1998
OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolatesF Danel, L M Hall, D Gur, et al.Pageof 30